What happened: A US advisory panel decided to no longer recommend the hepatitis B vaccine for all newborns, suggesting vaccination decisions be made individually for babies born to mothers without the virus.
Why it matters:
- This change could affect vaccination rates and public health strategies for hepatitis B prevention.
- Parents and healthcare providers will need to assess risks on a case-by-case basis, potentially impacting newborn health outcomes.
MNN Take: The panel's decision shifts from a blanket approach to a more tailored vaccination strategy, focusing on individual risk assessment rather than universal newborn immunisation.
Sources: BBC US & Canada